Puma Biotechnology Inc (NASDAQ:PBYI) has won FDA approval for its lead candidate Nerlynx (neratinib), sending shares up 9% in Tuesday’s trading session. The drug …
J.P.
In a 12-4 vote, the FDA’s Oncologic Drugs Advisory Committee (ODAC) supported the approval of Puma Biotechnology Inc’s (NASDAQ:PBYI) breast cancer drug neratinib, sending the drug maker’s shares …
It is a good day to be a Puma Biotechnology Inc (NASDAQ:PBYI) investors, with shares soaring 38% and FDA sentiment looking favorably on …
It’s a very rewarding trading day for investors in Puma Biotechnology Inc (NASDAQ:PBYI) with shares up over 40%, making the stock Wall Street’s …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares skyrocketed over 65% this morning, after the drug maker announced top-line results from its AURA-LV Phase IIb study …
Today, while many news outlets attributed Puma Biotechnology Inc’s (NYSE:PBYI) collapse to the news that the biotech company is under investigation for allegedly failing to inform …
Monday turned out to be a nightmare for shareholders of biotech companies Dynavax Technologies Corporation (NASDAQ:DVAX) and Puma Biotechnology Inc (NYSE:PBYI), as the stocks …
Puma Biotechnology Inc (NYSE:PBYI) announced that the U.S.
